108 related articles for article (PubMed ID: 23810521)
1. Subsequent malignancies after photon versus proton radiation therapy.
Bekelman JE; Schultheiss T; Berrington De Gonzalez A
Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):10-2. PubMed ID: 23810521
[No Abstract] [Full Text] [Related]
2. Incidence of second malignancies among patients treated with proton versus photon radiation.
Chung CS; Yock TI; Nelson K; Xu Y; Keating NL; Tarbell NJ
Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):46-52. PubMed ID: 23778197
[TBL] [Abstract][Full Text] [Related]
3. Risk of second cancers after photon and proton radiotherapy: a review of the data.
Yock TI; Caruso PA
Health Phys; 2012 Nov; 103(5):577-85. PubMed ID: 23032887
[TBL] [Abstract][Full Text] [Related]
4. Comparative risk assessment of secondary cancer incidence after treatment of Hodgkin's disease with photon and proton radiation.
Schneider U; Lomax A; Lombriser N
Radiat Res; 2000 Oct; 154(4):382-8. PubMed ID: 11023601
[TBL] [Abstract][Full Text] [Related]
5. Pediatric CSI: are protons the only ethical approach?
Johnstone PA; McMullen KP; Buchsbaum JC; Douglas JG; Helft P
Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):228-30. PubMed ID: 23958143
[No Abstract] [Full Text] [Related]
6. Modelling recurrence and second cancer risks induced by proton therapy.
Manem VSK; Dhawan A
Math Med Biol; 2018 Sep; 35(3):347-361. PubMed ID: 29106564
[TBL] [Abstract][Full Text] [Related]
7. A review of dosimetric and toxicity modeling of proton versus photon craniospinal irradiation for pediatrics medulloblastoma.
Ho ESQ; Barrett SA; Mullaney LM
Acta Oncol; 2017 Aug; 56(8):1031-1042. PubMed ID: 28509599
[TBL] [Abstract][Full Text] [Related]
8. Predicted Rate of Secondary Malignancies Following Adjuvant Proton Versus Photon Radiation Therapy for Thymoma.
Vogel J; Lin L; Litzky LA; Berman AT; Simone CB
Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):427-433. PubMed ID: 28871993
[TBL] [Abstract][Full Text] [Related]
9. The risk of second primary cancers due to peripheral photon and neutron doses received during prostate cancer external beam radiation therapy.
Bezak E; Takam R; Yeoh E; Marcu LG
Phys Med; 2017 Oct; 42():253-258. PubMed ID: 28302493
[TBL] [Abstract][Full Text] [Related]
10. Photons - Radiobiological issues related to the risk of second malignancies.
Marcu LG
Phys Med; 2017 Oct; 42():213-220. PubMed ID: 28236557
[TBL] [Abstract][Full Text] [Related]
11. Impediments to Comparative Clinical Trials With Proton Therapy.
Cox JD
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):4-8. PubMed ID: 26684408
[No Abstract] [Full Text] [Related]
12. Special radiobiological features of second cancer risk after particle radiotherapy.
Trott KR
Phys Med; 2017 Oct; 42():221-227. PubMed ID: 29103987
[TBL] [Abstract][Full Text] [Related]
13. Response to "The rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer: a population-based study on 17,845 patients." (Int J Radiat Oncol Biol Phys 2010;76:342-348).
Froehner M; Wirth MP
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1279; author reply 1280. PubMed ID: 20542389
[No Abstract] [Full Text] [Related]
14. Assessment of radiation-induced second cancer risks in proton therapy and IMRT for organs inside the primary radiation field.
Paganetti H; Athar BS; Moteabbed M; A Adams J; Schneider U; Yock TI
Phys Med Biol; 2012 Oct; 57(19):6047-61. PubMed ID: 22968191
[TBL] [Abstract][Full Text] [Related]
15. In regards to Orlandi et al HED-19-0487.
Dagan R; Bryant C
Head Neck; 2019 Oct; 41(10):3736. PubMed ID: 31313872
[No Abstract] [Full Text] [Related]
16. Differences in Normal Tissue Response in the Esophagus Between Proton and Photon Radiation Therapy for Non-Small Cell Lung Cancer Using In Vivo Imaging Biomarkers.
Niedzielski JS; Yang J; Mohan R; Titt U; Mirkovic D; Stingo F; Liao Z; Gomez DR; Martel MK; Briere TM; Court LE
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):1013-1020. PubMed ID: 29063837
[TBL] [Abstract][Full Text] [Related]
17. [The issue of low doses in radiation therapy and impact on radiation-induced secondary malignancies].
Chargari C; Cosset JM
Bull Cancer; 2013 Dec; 100(12):1333-42. PubMed ID: 24257106
[TBL] [Abstract][Full Text] [Related]
18. The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma.
Brown LM; Howard RA; Travis LB
Cancer; 2006 Dec; 107(11):2741-2; author reply 2742. PubMed ID: 17039496
[No Abstract] [Full Text] [Related]
19. The impact of protons on the incidence of second malignancies in radiotherapy by Eric J. Hall; Supp.31-34 2007.
Paganetti H
Technol Cancer Res Treat; 2007 Dec; 6(6):661-2. PubMed ID: 17994798
[No Abstract] [Full Text] [Related]
20. Radiation-induced second malignancies.
Mahmood S; Vu K; Tai P; Joseph K; Koul R; Dubey A; Yu E
Anticancer Res; 2015 Apr; 35(4):2431-4. PubMed ID: 25862910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
